A detailed history of Financial Advocates Investment Management transactions in Novartis Ag stock. As of the latest transaction made, Financial Advocates Investment Management holds 9,103 shares of NVS stock, worth $896,190. This represents 0.06% of its overall portfolio holdings.

Number of Shares
9,103
Previous 9,324 2.37%
Holding current value
$896,190
Previous $992,000 5.54%
% of portfolio
0.06%
Previous 0.06%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$106.13 - $120.89 $23,454 - $26,716
-221 Reduced 2.37%
9,103 $1.05 Million
Q2 2024

Jul 26, 2024

SELL
$92.57 - $107.37 $57,485 - $66,676
-621 Reduced 6.24%
9,324 $992,000
Q1 2024

May 01, 2024

SELL
$95.27 - $108.47 $14,862 - $16,921
-156 Reduced 1.54%
9,945 $961,000
Q3 2023

Oct 27, 2023

SELL
$94.73 - $105.13 $25,861 - $28,700
-273 Reduced 2.63%
10,101 $1.03 Million
Q2 2023

Aug 07, 2023

SELL
$92.52 - $104.91 $1,387 - $1,573
-15 Reduced 0.14%
10,374 $1.05 Million
Q1 2023

May 11, 2023

SELL
$80.03 - $92.81 $51,779 - $60,048
-647 Reduced 5.86%
10,389 $955,000
Q4 2022

Feb 14, 2023

SELL
$75.55 - $92.52 $5.01 Million - $6.13 Million
-66,256 Reduced 85.72%
11,036 $1 Million
Q3 2022

Nov 14, 2022

BUY
$74.61 - $87.26 $4.94 Million - $5.78 Million
66,233 Added 598.91%
77,292 $901,000
Q2 2022

Aug 12, 2022

SELL
$80.52 - $93.75 $5,153 - $6,000
-64 Reduced 0.58%
11,059 $935,000
Q1 2022

May 11, 2022

BUY
$80.11 - $90.62 $26,997 - $30,538
337 Added 3.12%
11,123 $976,000
Q4 2021

Feb 14, 2022

BUY
$79.7 - $88.13 $478 - $528
6 Added 0.06%
10,786 $944,000
Q3 2021

Nov 04, 2021

BUY
$81.78 - $95.14 $13,820 - $16,078
169 Added 1.59%
10,780 $881,000
Q2 2021

Aug 03, 2021

SELL
$85.24 - $94.15 $272,341 - $300,809
-3,195 Reduced 23.14%
10,611 $968,000
Q1 2021

May 10, 2021

SELL
$83.5 - $98.47 $33,901 - $39,978
-406 Reduced 2.86%
13,806 $1.09 Million
Q4 2020

Feb 12, 2021

SELL
$78.07 - $94.43 $12,959 - $15,675
-166 Reduced 1.15%
14,212 $1.34 Million
Q3 2020

Nov 04, 2020

SELL
$82.14 - $91.0 $17,742 - $19,656
-216 Reduced 1.48%
14,378 $1.25 Million
Q2 2020

Aug 14, 2020

SELL
$80.93 - $91.1 $19,018 - $21,408
-235 Reduced 1.58%
14,594 $1.28 Million
Q1 2020

Apr 29, 2020

SELL
$70.67 - $99.01 $7,491 - $10,495
-106 Reduced 0.71%
14,829 $1.22 Million
Q4 2019

Feb 13, 2020

BUY
$84.35 - $95.37 $161,108 - $182,156
1,910 Added 14.66%
14,935 $1.41 Million
Q3 2019

Nov 13, 2019

SELL
$85.54 - $94.26 $9,837 - $10,839
-115 Reduced 0.88%
13,025 $1.13 Million
Q2 2019

Aug 08, 2019

SELL
$75.4 - $92.8 $65,070 - $80,086
-863 Reduced 6.16%
13,140 $1.2 Million
Q1 2019

May 16, 2019

SELL
$75.32 - $86.15 $19,432 - $22,226
-258 Reduced 1.81%
14,003 $1.35 Million
Q4 2018

Feb 14, 2019

SELL
$73.66 - $82.02 $11,859 - $13,205
-161 Reduced 1.12%
14,261 $1.1 Million
Q3 2018

Nov 14, 2018

SELL
$66.94 - $77.43 $27,512 - $31,823
-411 Reduced 2.77%
14,422 $0
Q2 2018

Aug 09, 2018

SELL
$64.91 - $73.36 $40,114 - $45,336
-618 Reduced 4.0%
14,833 $1.11 Million
Q1 2018

May 11, 2018

BUY
$70.39 - $84.15 $74,331 - $88,862
1,056 Added 7.34%
15,451 $1.25 Million
Q4 2017

Feb 15, 2018

BUY
$72.33 - $77.64 $1.04 Million - $1.12 Million
14,395
14,395 $1.21 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Financial Advocates Investment Management Portfolio

Follow Financial Advocates Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Advocates Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Financial Advocates Investment Management with notifications on news.